Antivirals
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
EFAVIRENZ/TENOFOVIR DISOPROXIL FUMARATE/EMTRICITABINE: products 1 to 7 of 7.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Efavirenz-Emtricitabine-Tenofovir 600mg/300mg/200mg TabDIN 02468247 | General benefit | $11.3300per source unit | Requirements & sourcesBuild cost plan |
| Atripla 600mg/300mg/200mg TabDIN 02300699 | General benefit | $11.3300per source unit | Requirements & sourcesBuild cost plan |
| Auro-Efavirenz-Emtricitabine-Tenofovir 600mg/300mg/200mg TabDIN 02478404 | General benefit | $11.3300per source unit | Requirements & sourcesBuild cost plan |
| Jamp Efavirenz/Emtricitabine/Tenofovir 600mg/300mg/200mg TabDIN 02519461 | General benefit | $11.3300per source unit | Requirements & sourcesBuild cost plan |
| Mylan-Efavirenz/Emtricitabine/Tenofovir 600mg/300mg/200mg TabDIN 02461412 | General benefit | $11.3300per source unit | Requirements & sourcesBuild cost plan |
| PMS-Efavirenz-Emtricitabine-Tenofovir 600mg/300mg/200mg TabDIN 02487284 | General benefit | $11.3300per source unit | Requirements & sourcesBuild cost plan |
| Teva-Efavirenz/Emtricitabine/Tenofovir 600mg/300mg/200mg TabDIN 02393549 | General benefit | $11.3300per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
08:18 Antivirals.